News

ISTA Pharmaceuticals has asked the FDA not to give tentative or final approval of any abbreviated new drug application for bromfenac sodium ophthalmic solution 0.09% that uses the labeling for the company?s discontinued twice-daily brand (Xibrom) or omits any portion of the label for its once-daily brand (Bromday) relating to the once-daily dosing.

If your practice employs opticians, nurses, occupational therapists, physical therapists, or others who teach people who are visually impaired, they may be interested in a new online course from Lighthouse International.

You now can browse high-resolution images, order, and track your REM Eyewear orders through the VisionWeb portal, www.visionweb.com, because REM Eyewear has joined the VisionWeb network of suppliers.

You have until April 1 to apply for Prevent Blindness America?s Eighth Annual Investigator Awards.

Make sure your patients know about Bausch + Lomb?s voluntary recall of all lots of an eye drop (Soothe Xtra Protection [XP]).

Carl Zeiss Meditec has opened its Center for Application and Research (CARIn) near the company?s 14-year-old sales and service company in Bangalore, India, in an effort to strengthen its presence in high-growth markets and target its investments in research and development projects.

The FDA has granted Ocular Systems Inc. (OS) 501(K) clearance to market its human corneal endothelium delivery instrument, the EndoSerter. For use during endothlelial keratoplasty, this instrument delivers a corneal endothelail allograft less than or equal to 8.5 mm in diameter and less than or equal to 175 micrograms in central thickness through a single 4-mm incision.

A proprietary fluorescein sodium and lissamine green dye combination has shown favorable results for evaluating the ocular surface.

The mandatory implementation of electronic health records looms in 2014 for health-care professionals and hospital providers.

While U.S. ophthalmologists continue to await FDA approval of the dual-optic accommodating IOL, accumulating data from a number of investigations are providing evidence about the long-term performance of this novel presbyopia-correcting implant technology.

A newer form of endothelial keratoplasty - DMEK - provides better visual and refractive outcomes compared with Descemet's stripping automated endothelial keratoplasty.

In young patients who present with low-to-moderate myopia, minimal astigmatism, and excellent optics, there is no doubt that wavefront-guided LASIK with femtosecond laser flap creation is the refractive surgery procedure of choice.

Glistenings are common in the hydrophobic acrylic material of certain foldable IOLs, but they are not visually significant.

Consent forms signed before refractive surgery procedures do not suffice as evidence of informed consent.

The author tackles the issue of medical errors from a unique perspective.

Dog bite injuries frequently affect the periocular area, and clinicians should be familiar with the clinical examination, as well as the surgical and medical management paths to take in such cases.

Accumulation of toxins in the retina resulting from environmental and/or genetic factors causes retinal degeneration.

Local therapy with intravitreal sustained-release implants may have a place in the management of ocular infectious and inflammatory diseases, especially when the benefits are weighed against those involved with systemic therapy for patients.

A rebate Genentech offers large-volume purchasers of its ranibizumab has stirred debate over the propriety of rewarding physicians for treating their patients with expensive drugs.

The quality of communication between ophthalmologists and their patients with glaucoma can be improved by physician education.

Implantable lenses may be a viable option for vision correction in patients with high myopia, and in those who have thin corneas or conditions that might predispose them to complications with LASIK.

Mydriatic eye drops do not seem to affect cognitive function, based on results of cognitive testing.

Staggered management- consisting of medical therapy, argon laser, and cyclopexy - is beneficial in patients with cyclodialysis cleft.

The annual American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL, and Refractive Surgery will be held here Friday, March 25, to Tuesday, March 29.

As a busy eye-care facility, Clayton Eye Center in Morrow, GA, employs four ophthalmologists and seven optometrists who see as many as 200 patients daily.

Although many treatments have been tried, there remain no proven effective therapies to treat nonarteritic anterior ischemic optic neuropathy.

Prevent Blindness America (PBA) has commended the recent recommendation by the U.S. Preventive Services Task Force (USPSTF) for vision screening of all children aged 3 to 5 years. The USPSTF recommendation updates the task force?s 2004 recommendation of vision screening for all children aged fewer than 5 years. The USPSTF now recommends vision screening for the presence of amblyopia and its risk factors for all children aged 3 to 5 years.

After many years as a partner and supporter of Prevent Blindness America (PBA), Allergan Inc. has awarded PBA an advocacy grant to provide funding for The Eye Care Advocacy Network (Eye CAN).

Dipak Panigrahi, MD, senior vice president, research and development, and chief medical officer of QLT has stepped down from his position with QLT.

Prevent Blindness America (PBA) held its 6th annual "Eyes on Capitol Hill" event on March 2. This annual event was designed to give community leaders and patient advocates the opportunity to meet with government representatives to discuss vision issues.